The CEO of AstraZeneca, a multinational pharmaceutical company that has signed a contract with the Korean government to supply a vaccine for Corona 19, is confident of the success of the vaccine.
Pascal Sorio Astra, CEO of Astra, told The Times’ Sunday Times on the 27th local time that, like other competitors, “I seem to have figured out a formula for success that can benefit from two doses of the vaccine.”
CEO Sorio also said that “100% can be prevented” by vaccination against COVID-19 infection, which is severe enough to require hospitalization, but did not explain specific details.
The COVID-19 vaccine developed by AstraZeneca and Oxford University was controversial as the results of the interim analysis of the phase 3 clinical trial showed that the immune effect was different depending on the dosage and the immune effect was lower than that of Pfizer and Modena.
AstraZeneca applied for emergency use of the Corona 19 vaccine to the UK Drug and Health Care Product Regulatory Authority on the 21st, and the emergency use approval will be issued as early as the 27th, the Daily Telegraph reported.
Meanwhile, CEO Sorio said that AstraZeneca and Oxford University are currently working on a new version of the vaccine against the COVID-19 mutant virus.